ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,616Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 223

$708K Total Retail Price of All Prescriptions

Rank: 24 out of 223

491 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 9,820 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 618 544 1 3
PRAVASTATIN SODIUM 452 416 2 15
AMLODIPINE BESYLATE 416 379 3 6
FUROSEMIDE 330 296 4 9
LEVOTHYROXINE SODIUM 325 298 5 2
LOSARTAN POTASSIUM 281 276 6 14
METOPROLOL SUCCINATE 279 237 7 20
LISINOPRIL 259 237 8 4
ATORVASTATIN CALCIUM 217 213 9 17
SIMVASTATIN 210 208 10 1
POTASSIUM CHLORIDE 201 181 11 12
CARVEDILOL 195 185 12 23
HYDROCHLOROTHIAZIDE 193 188 13 13
ALENDRONATE SODIUM 180 180 14 19
ZOLPIDEM TARTRATE 167 163 15 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 156 152 16 29
CRESTOR 152 150 17 37
HYDROCODONE-ACETAMINOPHEN 150 124 S3 18 5
LOSARTAN-HYDROCHLOROTHIAZIDE 146 137 19 31
METFORMIN HCL 139 130 20 7
TRAMADOL HCL 135 129 21 18
GABAPENTIN 126 124 22 10
TAMSULOSIN HCL 126 126 22 26
SYNTHROID 122 122 24 35
CITALOPRAM HBR 110 108 25 16
ALLOPURINOL 108 96 26 28
GLIPIZIDE ER 108 108 26 98
FLUTICASONE PROPIONATE 107 101 28 27
DOXAZOSIN MESYLATE 104 97 29 60
FLUOXETINE HCL 99 92 30 24
SERTRALINE HCL 92 82 31 21
FINASTERIDE 92 86 31 58
WARFARIN SODIUM 89 89 33 11
DIOVAN 89 89 33 54
METFORMIN HCL ER 77 71 35 41
TRAZODONE HCL 75 75 36 22
EVISTA 73 73 37 92
HYDRALAZINE HCL 71 67 38 145
PANTOPRAZOLE SODIUM 70 59 39 45
LANTUS SOLOSTAR 69 61 40 74
ZETIA 66 60 41 68
CELEBREX 64 57 42 42
ATENOLOL 64 64 42 32
CYMBALTA 61 57 44 40
GLIMEPIRIDE 60 59 45 30
LANTUS 56 30 46 34
METOPROLOL TARTRATE 54 54 47 25
FENOFIBRATE 52 29 48 38
ESCITALOPRAM OXALATE 51 51 49 104
VERAPAMIL ER 51 51 49 89
VENLAFAXINE HCL ER 50 36 51 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 45 51 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.